vs
Dominari Holdings Inc.（DOMH）与Sol-Gel Technologies Ltd.（SLGL）财务数据对比。点击上方公司名可切换其他公司
Dominari Holdings Inc.的季度营收约是Sol-Gel Technologies Ltd.的1.7倍（$30.1M vs $17.3M），Sol-Gel Technologies Ltd.净利率更高（67.3% vs -438.1%，领先505.4%），Dominari Holdings Inc.同比增速更快（220.4% vs 217.7%）
Sol-Gel Technologies Ltd.是一家专注皮肤科药物研发的专业生物制药企业，依托专有溶胶凝胶递送技术开发痤疮、玫瑰痤疮、特应性皮炎等常见皮肤疾病的外用治疗方案，核心市场覆盖北美与欧洲，与医疗行业知名企业合作推进产品商业化。
DOMH vs SLGL — 直观对比
营收规模更大
DOMH
是对方的1.7倍
$17.3M
营收增速更快
DOMH
高出2.7%
217.7%
净利率更高
SLGL
高出505.4%
-438.1%
损益表 — Q4 FY2025 vs Q2 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $30.1M | $17.3M |
| 净利润 | $-131.8M | $11.6M |
| 毛利率 | — | — |
| 营业利润率 | -8.9% | 65.1% |
| 净利率 | -438.1% | 67.3% |
| 营收同比 | 220.4% | 217.7% |
| 净利润同比 | -12426.2% | 487.6% |
| 每股收益（稀释后） | $-6.94 | $4.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DOMHSLGL
| Q4 25 | $30.1M | — | ||
| Q3 25 | $50.8M | — | ||
| Q2 25 | $34.1M | $17.3M | ||
| Q1 25 | $8.1M | — | ||
| Q4 24 | $9.4M | — | ||
| Q3 24 | $4.0M | — | ||
| Q2 24 | $6.2M | $5.4M | ||
| Q1 24 | $1.4M | — |
净利润DOMHSLGL
| Q4 25 | $-131.8M | — | ||
| Q3 25 | $125.2M | — | ||
| Q2 25 | $16.6M | $11.6M | ||
| Q1 25 | $-32.5M | — | ||
| Q4 24 | $1.1M | — | ||
| Q3 24 | $-4.2M | — | ||
| Q2 24 | $-6.1M | $2.0M | ||
| Q1 24 | $-5.4M | — |
营业利润率DOMHSLGL
| Q4 25 | -8.9% | — | ||
| Q3 25 | -3.1% | — | ||
| Q2 25 | -57.0% | 65.1% | ||
| Q1 25 | -394.6% | — | ||
| Q4 24 | 0.4% | — | ||
| Q3 24 | -79.1% | — | ||
| Q2 24 | -44.3% | 29.9% | ||
| Q1 24 | -205.2% | — |
净利率DOMHSLGL
| Q4 25 | -438.1% | — | ||
| Q3 25 | 246.4% | — | ||
| Q2 25 | 48.7% | 67.3% | ||
| Q1 25 | -400.5% | — | ||
| Q4 24 | 11.4% | — | ||
| Q3 24 | -104.2% | — | ||
| Q2 24 | -99.1% | 36.4% | ||
| Q1 24 | -398.0% | — |
每股收益（稀释后）DOMHSLGL
| Q4 25 | $-6.94 | — | ||
| Q3 25 | $7.27 | — | ||
| Q2 25 | $1.12 | $4.17 | ||
| Q1 25 | $-3.02 | — | ||
| Q4 24 | $0.21 | — | ||
| Q3 24 | $-0.67 | — | ||
| Q2 24 | $-1.01 | $0.71 | ||
| Q1 24 | $-0.91 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $80.5M | $24.3M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $69.4M | $31.9M |
| 总资产 | $112.9M | $39.3M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资DOMHSLGL
| Q4 25 | $80.5M | — | ||
| Q3 25 | $176.2M | — | ||
| Q2 25 | $28.2M | $24.3M | ||
| Q1 25 | $18.9M | — | ||
| Q4 24 | $8.2M | — | ||
| Q3 24 | $7.2M | — | ||
| Q2 24 | $12.1M | $26.5M | ||
| Q1 24 | $7.1M | — |
股东权益DOMHSLGL
| Q4 25 | $69.4M | — | ||
| Q3 25 | $210.2M | — | ||
| Q2 25 | $88.6M | $31.9M | ||
| Q1 25 | $42.4M | — | ||
| Q4 24 | $39.9M | — | ||
| Q3 24 | $38.3M | — | ||
| Q2 24 | $42.4M | $34.9M | ||
| Q1 24 | $47.7M | — |
总资产DOMHSLGL
| Q4 25 | $112.9M | — | ||
| Q3 25 | $223.4M | — | ||
| Q2 25 | $109.3M | $39.3M | ||
| Q1 25 | $52.3M | — | ||
| Q4 24 | $47.1M | — | ||
| Q3 24 | $43.4M | — | ||
| Q2 24 | $49.1M | $42.0M | ||
| Q1 24 | $52.2M | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $22.7M | — |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流DOMHSLGL
| Q4 25 | $22.7M | — | ||
| Q3 25 | $-4.9M | — | ||
| Q2 25 | $-353.0K | — | ||
| Q1 25 | $1.2M | — | ||
| Q4 24 | $-16.7M | — | ||
| Q3 24 | $-4.7M | — | ||
| Q2 24 | $1.4M | — | ||
| Q1 24 | $-8.6M | — |
现金转化率DOMHSLGL
| Q4 25 | — | — | ||
| Q3 25 | -0.04× | — | ||
| Q2 25 | -0.02× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -15.65× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DOMH
| Chief Operating Decision Maker | $30.1M | 100% |
| Commissions | $458.0K | 2% |
SLGL
暂无分部数据
